United States Insulin (API & Injection) Market Report 2016

November 2016 | 97 pages | ID: U7943D4FBABEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Insulin (API & Injection)

Revenue, means the sales value of Insulin (API & Injection)

This report studies sales (consumption) of Insulin (API & Injection) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novo Nordisk
• Eli Lilly
• Sanofi-Aventis
• Dongbao
• Bioton
• United Laboratories
• Merck
• Ganlee

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Animal Insulin
• Human Insulin
• Insulin Analogue

Split by applications, this report focuses on sales, market share and growth rate of Insulin (API & Injection) in each application, can be divided into

• Short acting
• Interme diate acting insulin
• Long acting insulin
• Pre-mix Insulin

Contents

United States Insulin (API & Injection) Market Report 2016

1 INSULIN (API & INJECTION) OVERVIEW

1.1 Product Overview and Scope of Insulin (API & Injection)
1.2 Classification of Insulin (API & Injection)
  1.2.1 Animal Insulin
  1.2.2 Human Insulin
  1.2.3 Insulin Analogue
1.3 Application of Insulin (API & Injection)
  1.3.1 Short acting
  1.3.2 Interme diate acting insulin
  1.3.3 Long acting insulin
  1.3.4 Pre-mix Insulin
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Insulin (API & Injection) (2011-2021)
  1.4.1 United States Insulin (API & Injection) Sales and Growth Rate (2011-2021)
  1.4.2 United States Insulin (API & Injection) Revenue and Growth Rate (2011-2021)

2 UNITED STATES INSULIN (API & INJECTION) COMPETITION BY MANUFACTURERS

2.1 United States Insulin (API & Injection) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Insulin (API & Injection) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Insulin (API & Injection) Average Price by Manufactures (2015 and 2016)
2.4 Insulin (API & Injection) Market Competitive Situation and Trends
  2.4.1 Insulin (API & Injection) Market Concentration Rate
  2.4.2 Insulin (API & Injection) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES INSULIN (API & INJECTION) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Insulin (API & Injection) Sales and Market Share by Type (2011-2016)
3.2 United States Insulin (API & Injection) Revenue and Market Share by Type (2011-2016)
3.3 United States Insulin (API & Injection) Price by Type (2011-2016)
3.4 United States Insulin (API & Injection) Sales Growth Rate by Type (2011-2016)

4 UNITED STATES INSULIN (API & INJECTION) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Insulin (API & Injection) Sales and Market Share by Application (2011-2016)
4.2 United States Insulin (API & Injection) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES INSULIN (API & INJECTION) MANUFACTURERS PROFILES/ANALYSIS

5.1 Novo Nordisk
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Insulin (API & Injection) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novo Nordisk Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Eli Lilly
  5.2.2 Insulin (API & Injection) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Eli Lilly Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi-Aventis
  5.3.2 Insulin (API & Injection) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi-Aventis Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Dongbao
  5.4.2 Insulin (API & Injection) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Dongbao Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bioton
  5.5.2 Insulin (API & Injection) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bioton Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 United Laboratories
  5.6.2 Insulin (API & Injection) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 United Laboratories Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Merck
  5.7.2 Insulin (API & Injection) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Merck Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Ganlee
  5.8.2 Insulin (API & Injection) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Ganlee Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 INSULIN (API & INJECTION) MANUFACTURING COST ANALYSIS

6.1 Insulin (API & Injection) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Insulin (API & Injection)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Insulin (API & Injection) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Insulin (API & Injection) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES INSULIN (API & INJECTION) MARKET FORECAST (2016-2021)

10.1 United States Insulin (API & Injection) Sales, Revenue Forecast (2016-2021)
10.2 United States Insulin (API & Injection) Sales Forecast by Type (2016-2021)
10.3 United States Insulin (API & Injection) Sales Forecast by Application (2016-2021)
10.4 Insulin (API & Injection) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Insulin (API & Injection)
Table Classification of Insulin (API & Injection)
Figure United States Sales Market Share of Insulin (API & Injection) by Type in 2015
Figure Animal Insulin Picture
Figure Human Insulin Picture
Figure Insulin Analogue Picture
Table Application of Insulin (API & Injection)
Figure United States Sales Market Share of Insulin (API & Injection) by Application in 2015
Figure Short acting Examples
Figure Interme diate acting insulin Examples
Figure Long acting insulin Examples
Figure Pre-mix Insulin Examples
Figure United States Insulin (API & Injection) Sales and Growth Rate (2011-2021)
Figure United States Insulin (API & Injection) Revenue and Growth Rate (2011-2021)
Table United States Insulin (API & Injection) Sales of Key Manufacturers (2015 and 2016)
Table United States Insulin (API & Injection) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Insulin (API & Injection) Sales Share by Manufacturers
Figure 2016 Insulin (API & Injection) Sales Share by Manufacturers
Table United States Insulin (API & Injection) Revenue by Manufacturers (2015 and 2016)
Table United States Insulin (API & Injection) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Insulin (API & Injection) Revenue Share by Manufacturers
Table 2016 United States Insulin (API & Injection) Revenue Share by Manufacturers
Table United States Market Insulin (API & Injection) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Insulin (API & Injection) Average Price of Key Manufacturers in 2015
Figure Insulin (API & Injection) Market Share of Top 3 Manufacturers
Figure Insulin (API & Injection) Market Share of Top 5 Manufacturers
Table United States Insulin (API & Injection) Sales by Type (2011-2016)
Table United States Insulin (API & Injection) Sales Share by Type (2011-2016)
Figure United States Insulin (API & Injection) Sales Market Share by Type in 2015
Table United States Insulin (API & Injection) Revenue and Market Share by Type (2011-2016)
Table United States Insulin (API & Injection) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Insulin (API & Injection) by Type (2011-2016)
Table United States Insulin (API & Injection) Price by Type (2011-2016)
Figure United States Insulin (API & Injection) Sales Growth Rate by Type (2011-2016)
Table United States Insulin (API & Injection) Sales by Application (2011-2016)
Table United States Insulin (API & Injection) Sales Market Share by Application (2011-2016)
Figure United States Insulin (API & Injection) Sales Market Share by Application in 2015
Table United States Insulin (API & Injection) Sales Growth Rate by Application (2011-2016)
Figure United States Insulin (API & Injection) Sales Growth Rate by Application (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Insulin (API & Injection) Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Insulin (API & Injection) Sales Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis Insulin (API & Injection) Sales Market Share (2011-2016)
Table Dongbao Basic Information List
Table Dongbao Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dongbao Insulin (API & Injection) Sales Market Share (2011-2016)
Table Bioton Basic Information List
Table Bioton Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bioton Insulin (API & Injection) Sales Market Share (2011-2016)
Table United Laboratories Basic Information List
Table United Laboratories Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Laboratories Insulin (API & Injection) Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Insulin (API & Injection) Sales Market Share (2011-2016)
Table Ganlee Basic Information List
Table Ganlee Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ganlee Insulin (API & Injection) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin (API & Injection)
Figure Manufacturing Process Analysis of Insulin (API & Injection)
Figure Insulin (API & Injection) Industrial Chain Analysis
Table Raw Materials Sources of Insulin (API & Injection) Major Manufacturers in 2015
Table Major Buyers of Insulin (API & Injection)
Table Distributors/Traders List
Figure United States Insulin (API & Injection) Production and Growth Rate Forecast (2016-2021)
Figure United States Insulin (API & Injection) Revenue and Growth Rate Forecast (2016-2021)
Table United States Insulin (API & Injection) Production Forecast by Type (2016-2021)
Table United States Insulin (API & Injection) Consumption Forecast by Application (2016-2021)